Sittner & Nelson’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $313K | Hold |
8,153
| – | – | 0.13% | 114 |
|
|
2025
Q1 | $316K | Buy |
8,153
+3,000
| +58% | +$116K | 0.13% | 105 |
|
|
2024
Q4 | $174K | Sell |
5,153
-5,200
| -50% | -$176K | 0.08% | 140 |
|
|
2024
Q3 | $423K | Buy |
10,353
+3,000
| +41% | +$123K | 0.19% | 78 |
|
|
2024
Q2 | $283K | Hold |
7,353
| – | – | 0.14% | 90 |
|
|
2024
Q1 | $315K | Sell |
7,353
-750
| -9% | -$32.2K | 0.16% | 91 |
|
|
2023
Q4 | $300K | Buy |
8,103
+2,684
| +50% | +$99.5K | 0.16% | 87 |
|
|
2023
Q3 | $196K | Hold |
5,419
| – | – | 0.11% | 106 |
|
|
2023
Q2 | $193K | Sell |
5,419
-6,787
| -56% | -$242K | 0.11% | 110 |
|
|
2023
Q1 | $434K | Buy |
12,206
+415
| +4% | +$14.8K | 0.25% | 68 |
|
|
2022
Q4 | $414K | Buy |
11,791
+260
| +2% | +$9.14K | 0.25% | 73 |
|
|
2022
Q3 | $339K | Buy |
11,531
+5,037
| +78% | +$148K | 0.23% | 75 |
|
|
2022
Q2 | $353K | Sell |
6,494
-600
| -8% | -$32.6K | 0.23% | 78 |
|
|
2022
Q1 | $386K | Buy |
7,094
+39
| +0.6% | +$2.12K | 0.22% | 75 |
|
|
2021
Q4 | $389K | Sell |
7,055
-31
| -0.4% | -$1.71K | 0.23% | 72 |
|
|
2021
Q3 | $338K | Buy |
7,086
+1,200
| +20% | +$57.2K | 0.22% | 73 |
|
|
2021
Q2 | $293K | Hold |
5,886
| – | – | 0.21% | 70 |
|
|
2021
Q1 | $263K | Buy |
5,886
+100
| +2% | +$4.47K | 0.2% | 74 |
|
|
2020
Q4 | $266K | Buy |
+5,786
| New | +$266K | 0.24% | 72 |
|